Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0700

+1.4%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: NTTG who wrote (11668)	11/16/2012 2:40:52 PM
From: Mimbari	4 Recommendations Read Replies (1) of 13111

NTTG is wrong. Most drugs take 15 years to get to market at over one billion dollars. PV-10 is farther along at this point than most and at 100 million or so spent at this time. The generous compensation was suggested and approved by the bigger shareholders as a means to keep the talent right where they are and happy because they have all received lucrative job offers elsewhere. Those that are unhappy with the share price now will soon have nothing to complain about. Nothing is standing still. It is my belief that the lower share price is market makers driving it down to buy it up. They are wise enough to see that the payoff should occur within this next year. Pharma stocks are a gamble but it is my belief that this is a gamble worth taking. In addition, one cannot hurry the FDA, they have their own timeline and nothing you can do will change that. At the moment the ball is in the FDA court.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next